Cardiovascular manifestations seen in obstructive sleep apnea.
Patients with obstructive sleep apnea (OSA) have an increased prevalence of systemic and pulmonary hypertension, left ventricular (LV) hypertrophy, LV systolic and diastolic dysfunction, and congestive heart failure, increased platelet aggregability, and increased susceptibility to thrombotic and embolic cardiac and cerebrovascular events. Patients with OSA have an increased prevalence of coronary artery disease, myocardial infarction, nocturnal angina, and myocardial ischemia, arrhythmias, and sudden cardiac death. Patients with OSA also have an increased prevalence of stroke. Treatment of OSA with continuous positive airway pressure improves cardiac efficiency in patients with heart failure, causes a reduction in the frequency of nocturnal ischemic ST-segment depression, relieves nocturnal angina, and causes a reduction in the occurrence of new cardiovascular events and an increase in the time to such events.
Aronow
Wilbert S
WS
Department of Medicine, Division of Cardiology, New York Medical College, Valhalla, NY 10595, USA. WSAronow@aol.com
D001145:Arrhythmias, Cardiac / Q000150:complications; D002318:Cardiovascular Diseases / Q000150:complications*; D003324:Coronary Artery Disease / Q000150:complications; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D017379:Hypertrophy, Left Ventricular / Q000150:complications; D020181:Sleep Apnea, Obstructive / Q000150:complications*; D020521:Stroke / Q000150:complications